Next-Gen S1P Receptor Modulator Shows Promise in MS (CME/CE)

(MedPage Today) -- Two phase II trials demonstrate multiple benefits, but not in disability
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news
More News: Disability | Health